Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Efficacy and Safety of Doravirine-based Regimens by Sex and Race: Long-term Results From Three Phase 3 Clinical Trials.
Journal: Open forum infectious diseases
Published: December 10, 2024
Doravirine/Islatravir (100/0.75 mg) Once-Daily Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV-1 Treatment: 48-Week Results From a Phase 3, Randomized, Controlled, Double-Blind, Noninferiority Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 25, 2024
Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 03, 2021
Impact of Dapivirine and Placebo Vaginal Rings on the Microbiota of Adolescent, Lactating, and Postmenopausal Females.
Journal: The Journal of infectious diseases
Published: September 07, 2021
Influence of dapivirine vaginal ring use on cervicovaginal immunity and functional microbiome in adolescent girls.
Journal: AIDS (London, England)
Published: November 12, 2020
Qualitative Study on the Acceptability of and Adherence to a Vaginal Ring for HIV Prophylaxis Among Adolescent Girls.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: September 14, 2020
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: February 27, 2020
Brief Report: Phase IIa Safety Study of a Vaginal Ring Containing Dapivirine in Adolescent Young Women.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: January 14, 2020
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial.
Journal: The lancet. HIV
Published: April 10, 2019
Once-daily Doravirine for Initial Treatment of Adults Living With Human Immunodeficiency Virus-1: An Integrated Safety Analysis.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 31, 2019
Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily, With Emtricitabine and Tenofovir Disoproxil Fumarate, for Previously Untreated HIV-1 Infection: Week 96 Results From ONCEMRK, a Randomized, Double-Blind, Noninferiority Trial.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: May 18, 2018
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus-1 Infection: Week 48 Results of the DRIVE-AHEAD Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 28, 2018
Last Updated: 09/26/2026